ANA SCHROEDER: Open Payments
NPI 1588448989 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 83 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,951 · 2025 $1,727
Food & beverage: $1,627Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $573 |
| ABBVIE INC. | 28 | $423 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $221 |
| GENZYME CORPORATION | 7 | $159 |
| QOL Medical, LLC | 5 | $83 |
| Ardelyx, Inc. | 4 | $69 |
| Madrigal Pharmaceuticals | 2 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $24 |
Products named: TREMFYA, RINVOQ, DUPIXENT, LINZESS, SKYRIZI, ENTYVIO, EOHILIA, STELARA.
Industry payments across IN — which companies pay providers there.
